Pharma, hospitals, healthcare & life sciences
Bajaj Finance's QIP, Aurobindo Pharma's USFDA update, fresh Q2 numbers from Mishra Dhatu Nigam, Triveni Turbine and DCX Systems, and a major Aditya Infotech block deal are among Thursday's key stock market triggers.
Pharma gains while IT weakens, Vedant Poly Fabs lists flat, SEBI settlement rules take effect, and inflation data and the holiday-shortened week ahead — Monday midday market news.
India's hospital industry is attracting increasing attention as organised healthcare chains expand beyond their traditional metropolitan markets. Demand for specialised…
Explore Sai Life Sciences' business model, CRDMO services, drug discovery, pharma manufacturing, financial performance and future growth opportunities.
Lupin has spent decades building a pharmaceutical business around affordable medicines. Its products are sold across India, the United States…
Indian weekly earnings review for Oct 26–30, 2026: Reliance, Bajaj Auto, L&T, Sun Pharma, Asian Paints and 12 more Q2 FY27 results with key numbers.
Indian stock market weekly wrap for October 26–30, 2026: Nifty reclaims 23,000, pharma leads, FIIs turn buyers. Sector moves, flows and next week's calendar.
India's September-quarter earnings season ended another busy week with a string of important announcements from banking, pharmaceuticals, telecom, defence and…
Piramal Pharma is undergoing an important business transformation. The Indian pharmaceutical company is expanding its position in global drug development,…
Empire Industries Limited is one of India's lesser-known diversified companies, with business interests extending across pharmaceutical glass packaging, industrial machinery,…
October 26 Q2 results roundup with reported revenue and profit for Tata Consumer, Mankind Pharma, REC, IOB, Bank of Maharashtra, ITC Hotels, Ather Energy, APL Apollo, Sona BLW and Dalmia Bharat.
Sensex, Nifty today, October 26: Markets recover from early losses as pharma and banking stocks gain. Shriram Finance and Infosys decline.